Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biotech deals
Biotech
Regeneron signs Mammoth gene editing deal worth $100M upfront
Regeneron is signing another major deal in gene editing—and, this time, it’s Mammoth.
Annalee Armstrong
Apr 25, 2024 8:49am
To be better at neuroscience, Biogen will invest elsewhere
Apr 24, 2024 10:37am
How Vertex became the VIP of Alpine's exclusive data room
Apr 23, 2024 11:19am
Boehringer signs $1.3B MASH collab with RNA biotech Ochre
Apr 22, 2024 8:45am
Ipsen dives into $1.8B Skyhawk pact to fire up RNA modulator R&D
Apr 22, 2024 7:01am
Biopharma M&A more than doubled in Q1 compared to a year ago
Apr 18, 2024 9:46am